Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vegetative biofiltration systems for heavy metal removal: a PRISMA-based systematic review of global performance and key determinants.

Environmental science and pollution research international·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Towards efficient artificial intelligence techniques for the assessment of irrigation water quality: a systematic literature review.

Environmental science and pollution research international·2025
Same author

Comprehensive dataset for olive tree varieties responses to different level of drought stress.

Data in brief·2025
Same author

<i>Tetrapleura tetraptera</i> fruit phenolics fraction protects against the impact of ischemic stroke-induced hippocampal distortions and memory deficits in Wistar rats.

Anatomy & cell biology·2024

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Abbas Nasidi1, Uduak Emmanuel Umana2, Adamu Abubakar Sadeeq2

  • 1Bauchi State University, Gadau, Bauchi, Nigeria.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 24, 2025
PubMed
Summary

Cannabidiol (CBD) oil shows promise in improving motor and cognitive functions in Alzheimer's disease models. This research highlights CBD's potential to reduce key neuropathological markers associated with the disease.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder with no cure.
  • Cannabidiol (CBD), a cannabis-derived compound, possesses anti-inflammatory and neuroprotective properties.
  • This study explored CBD's effects on an Aβ42 transgenic AD model.

Purpose of the Study:

  • To investigate the neuroprotective potential of CBD.
  • To evaluate CBD's impact on neurobehavioral and morphological changes in an AD model.

Main Methods:

  • 150 flies were divided into five groups: controls, Donepezil, and CBD (2mg and 4mg).
  • Evaluated motor function, memory, social interaction, and levels of amyloid beta (Aβ42) and GFAP.
  • CBD was administered for two weeks.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Main Results:

  • AD model showed impaired motor function, memory, and social behavior, with elevated Aβ42 and GFAP.
  • CBD treatment, particularly at 4mg, significantly improved motor function, memory, and social interaction.
  • CBD administration reduced Aβ42 and GFAP levels, mitigating neuropathological changes.

Conclusions:

  • CBD oil demonstrates therapeutic potential for Alzheimer's disease.
  • CBD may mitigate motor and cognitive deficits and neuropathological changes in AD.
  • Further research is needed to explore CBD's mechanisms and optimize treatment for AD.